awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42363966-4496CE86-CFC7-41EE-899E-724974E35C02
Q42363966-4496CE86-CFC7-41EE-899E-724974E35C02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42363966-4496CE86-CFC7-41EE-899E-724974E35C02
Review article: effects of type 2 diabetes therapies on bone metabolism.
P2860
Q42363966-4496CE86-CFC7-41EE-899E-724974E35C02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42363966-4496CE86-CFC7-41EE-899E-724974E35C02
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41d14fcb3cd950cd03f4de24fd9823fa08b3ee29
P2860
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.